Chrysler
Summary
NHTSA campaign 22V426: Chrysler recalled for a safety defect. A vehicle that starts and shifts out of Park without applying the brake pedal can result in vehicle rollaway, increasing
Details
Source
nhtsa
External ID
22V426
Action Date
2022-06-15
Status
Ongoing
Category
vehicle
Product Description
Chrysler (FCA US, LLC) is recalling certain 2018-2019 Jeep Grand Cherokee and Dodge Durango vehicles. A malfunction in the antilock-brake system (ABS) module may illuminate the brake lights, and allow the vehicle to start and shift out of Park without the brake pedal being applied.
Company
Context & Analysis
Chrysler has 242 FDA actions in our database.
Frequently Asked Questions
How often does Chrysler have FDA actions?
Chrysler has 242 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle